GlassScriptPhysician profile
Murad Bani Hani
NPI 1659603678
$18,037.22
in general payments reported to CMS, 2019-2025
14 companies · $13K in 2025
The $13K reported for 2025 was more than what 94% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,861 · 2021: $32.26 · 2022: $431 · 2023: $147 · 2024: $744 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Travel and Lodging: $4,008 · Food and Beverage: $1,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Travel and Lodging | $4,008.04 |
| Food and Beverage | $1,705.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,554.63 | 2019-2025 | |
| Abbvie INC. | $610.98 | 2019-2025 | Rinvoq |
| Takeda Pharmaceuticals U.S.A., INC. | $191.20 | 2021-2024 | Entyvio |
| Boston Scientific Corporation | $145.98 | 2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Janssen Scientific Affairs, LLC | $125.41 | 2025 | Tremfya |
| Pfizer INC. | $104.60 | 2024 | |
| Medical Device Business Services, INC. | $89.01 | 2019 | |
| Conmed Corporation | $48.23 | 2022 | |
| Janssen Biotech, INC. | $41.81 | 2022-2025 | Tremfya |
| Lilly USA, LLC | $33.61 | 2024 | Omvoh |
| Ardelyx, INC. | $33.52 | 2023 | Ibsrela |
| Merck Sharp & Dohme LLC | $24.63 | 2022 | |
| Axonics, INC. | $19.59 | 2024 | Axonics |
| Braintree Laboratories, INC. | $14.02 | 2023 | Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murad Bani Hani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.